Exploring the role of neighborhood socio-demographic factors on HPV vaccine initiation among low-income, ethnic minority girls

Journal of Immigrant and Minority Health

Volumn 15, Issue 4, 2013, Pages 732-740

  Tsui, Jennifer ^a   Gee, Gilbert C ^b   Rodriguez, Hector P ^b   Kominski, Gerald F ^b   Glenn, Beth A ^b   Singhal, Rita ^c   Bastani, Roshan ^b  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Office of Women's Health   (United States)

Author keywords

Cervical cancer; Human papillomavirus (HPV) vaccine; Immigrant; Low income; Neighborhood characteristics

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ATTITUDE TO HEALTH; DEMOGRAPHY; ETHNOLOGY; FEMALE; HEALTH CARE DISPARITY; HUMAN; INFORMATION PROCESSING; INSURANCE; MOTHER; PAPILLOMAVIRUS INFECTION; PREVENTIVE HEALTH SERVICE; RESIDENTIAL CARE; STATISTICS AND NUMERICAL DATA; UNITED STATES; UTERINE CERVIX TUMOR;

ADOLESCENT; CATCHMENT AREA (HEALTH); DATA COLLECTION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTHCARE DISPARITIES; HUMANS; IMMUNIZATION PROGRAMS; INSURANCE COVERAGE; MOTHERS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; RESIDENCE CHARACTERISTICS; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

MLCS; MLOWN;

EID: 84880164549     PISSN: 15571912     EISSN: 15571920     Source Type: Journal    
DOI: 10.1007/s10903-012-9736-x     Document Type: Article

References (50)

1. American Cancer Society. Cancer facts and figures 2012. Atlanta: American Cancer Society; 2012. Accessed at http://www.cancer.org/acs/groups/content/ @epidemiologysurveilance/documents/document/acspc-031941.pdf.
2. Freeman HP, Wingrove BK. Excess cervical cancer mortality: a marker for low access to health care in poor communities. Rockville: National Cancer Institute, Center to Reduce Cancer Health Disparities; 2005.
3. Krieger N, et al. Social class, race/ethnicity, and incidence of breast, cervix, colon, lung, and prostate cancer among Asian, Black, Hispanic, and White residents of the San Francisco Bay Area, 1988-92 (United States). Cancer Causes Control. 1999;10(6):525-37.
4. McDougall JA, et al. Racial and ethnic disparities in cervical cancer incidence rates in the United States, 1992-2003. Cancer Causes Control. 2007;18(10):1175-86.
5. Saraiya M, et al. Cervical cancer incidence in a prevaccine era in the United States, 1998-2002. Obstet Gynecol. 2007;109(2 Pt 1):360-70.
6. Coughlin SS, et al. Contextual analysis of breast and cervical cancer screening and factors associated with health care access among United States women, 2002. Soc Sci Med. 2008;66(2):260-75.
7. Datta GD, et al. Individual-, neighborhood-, and state-level socioeconomic predictors of cervical carcinoma screening among U.S. black women: a multilevel analysis. Cancer. 2006;106(3):664-9.
8. Tsui J, et al. Cervical cancer screening among foreign-born women by birthplace and duration in the United States. J Womens Health (Larchmt). 2007;16(10):1447-57.
9. Ponce NA, et al. Is there a language divide in pap test use? Med Care. 2006;44(11):998-1004.
10. Coughlin SS, Uhler RJ. Breast and cervical cancer screening practices among Asian and Pacific Islander women in the United States, 1994-1997. Cancer Epidemiol Biomarkers Prev. 2000;9(6):597-603.
11. Krieger N, et al. Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: the Public Health Disparities Geocoding Project. Am J Epidemiol. 2002;156(5):471-82.
12. McCarthy AM, et al. Racial/ethnic and socioeconomic disparities in mortality among women diagnosed with cervical cancer in New York City, 1995-2006. Cancer Causes Control. 2010;21:1645.
13. Singh GK, Miller BA. Health, life expectancy, and mortality patterns among immigrant populations in the United States. Can J Public Health. 2004;95(3):I14-21.
14. CDC. Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). In: MMWR early release. Centers for Disease Control and Prevention; 2007. p. 1-24.
15. CDC. National, state, and local area vaccination coverage among adolescents aged 13 through 17 years - United States, 2011. In: Morbidity and mortality weekly report 2012. p. 671-677.
16. Bastani R, et al. Understanding suboptimal human papillomavirus vaccine uptake among ethnic minority girls. Cancer Epidemiol Biomarkers Prev. 2011;20(7):1463-72.
17. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007;45(2-3):107-14.
18. Cates JR, et al. Racial differences in HPV knowledge, HPV vaccine acceptability, and related beliefs among rural, southern women. J Rural Health. 2009;25(1):93-7.
19. Constantine NA, Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health. 2007;40(2):108-15.
20. Dempsey AF, et al. Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus. Ann Epidemiol. 2009;19(8):531-8.
21. Gerend MA, Weibley E, Bland H. Parental response to human papillomavirus vaccine availability: uptake and intentions. J Adolesc Health. 2009;45(5):528-31.
22. Hughes J, et al. Disparities in how parents are learning about the human papillomavirus vaccine. Cancer Epidemiol Biomarkers Prev. 2009;18(2):363-72.
23. Rosenthal SL, et al. Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health. 2008;43(3):239-45.
24. Tiro JA, et al. Multilevel correlates for human papillomavirus vaccination of adolescent girls attending safety net clinics. Vaccine. 2012;30(13):2368-75.
25. Acevedo-Garcia D. Residential segregation and the epidemiology of infectious diseases. Soc Sci Med. 2000;51(8):1143-61.
26. Kawachi I, Berkman LF. Neighborhoods and health. New York: Oxford University Press; 2003. p. 352.
27. Williams DR, Collins C. Racial residential segregation: a fundamental cause of racial disparities in health. Public Health Rep. 2001;116(5):404-16.
28. Achat H, et al. Social networks, stress and health-related quality of life. Q Life Res. 1998;7(8):735-50.
29. Borrell LN, et al. Neighbourhood characteristics and mortality in the Atherosclerosis Risk in Communities Study. Int J Epidemiol. 2004;33(2):398-407.
30. Browning CR, Cagney KA, Wen M. Explaining variation in health status across space and time: implications for racial and ethnic disparities in self-rated health. Soc Sci Med. 2003;57(7):1221-35.
31. Kirby JB, Kaneda T. Neighborhood socioeconomic disadvantage and access to health care. J Health Soc Behav. 2005;46(1):15-31.
32. Rogers EM. Diffusion of innovations. New York, NY: Free Press, A division of Simon & Schuster, Inc.; 2003.
33. CDC, ACIP-VFC. Vaccine resolutions for vaccines to prevent human Papillomavirus. 2011. p. 1-2.
34. Mobley LR, et al. Heterogeneity in mammography use across the nation: separating evidence of disparities from the disproportionate effects of geography. Int J Health Geogr. 2008;7:32.
35. Kawachi I, Berkman L. Social cohesion, social capital, and health. In: Social epidemiology. New York: Oxford University Press; 2000. p. 174-90.
36. Chao C, et al. Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol. 2010;171(3):357-67.
37. Pruitt SL, Schootman M. Geographic disparity, area poverty, and human papillomavirus vaccination. Am J Prev Med. 2010;38(5):525-33.
38. Bastani R, et al. Understanding suboptimal human papillomavirus vaccine uptake among ethnic minority girls. Cancer Epidemiol Biomarkers Prev. 2011;20(7):1463-72.
39. U.S. Census Bureau. American Community Survey. 2012 [cited 2012 March 10]; Available from: http://www.census.gov/acs/www/about-the-survey/american- community-survey/.
40. U.S. Census Bureau. U.S. Census Geographic Terms and Concepts. In: 2008 Redistricting Data Prototype (Public Law 94-171) Summary File U.S.C. Bureau, editor. 2008: Washington, D.C.
41. ACIP. ACIP Provisional Recommendations for HPV Vaccine. In: ACIP Meeting, October, 21, 2009. 2009. Atlanta.
42. Smith PJ, et al. Underinsurance and adolescent immunization delivery in the United States. Pediatrics. 2009;124(Suppl 5):S515-21.
43. Kneebone E, Nadeau C, Berube A. The re-emergence of concentrated poverty: metropolitan trends in the 2000s. In: Metropolitan Policy Program at Brookings, editor. Metropolitan opportunity series. Washington: The Brookings Institute; 2011.
44. Silver D, Blustein J, Weitzman BC. Transportation to clinic: findings from a pilot clinic-based survey of low-income suburbanites. J Immigr Minor Health. 2012;14(2):350-5.
45. Gowda C, Dempsey AF. Medicaid reimbursement and the uptake of adolescent vaccines. Vaccine, 2012.
46. Lavarreda SA, Brown ER, Bolduc CD. Underinsurance in the United States: an interaction of costs to consumers, benefit design, and access to care. Annu Rev Public Health. 2011;32:471-82.
47. Bednarczyk RA, Birkhead GS. Reducing financial barriers to vaccinating children and adolescents in the USA. Curr Opin Pediatr. 2011;23(1):105-9.
48. Freed GL, Cowan AE, Clark SJ. Primary care physician perspectives on reimbursement for childhood immunizations. Pediatrics. 2009;124(Suppl 5):S466-71.
49. Young JL, et al. Human papillomavirus vaccination recommendation may be linked to reimbursement: a survey of Virginia family practitioners and gynecologists. J Pediatr Adolesc Gynecol. 2011;24(6):380-5.
50. Schootman M, et al. Self-report by elderly breast cancer patients was an acceptable alternative to surveillance, epidemiology, and end results (SEER) abstract data. J Clin Epidemiol. 2005;58(12):1316-9.